AI deciphers how fast ALS progresses and which functions decline first

ALS (amyotrophic lateral sclerosis) is a fatal neurodegenerative disease that gradually affects a person's ability to move, speak and breathe. It advances differently in every patient. Now, researchers at Nagoya University have developed an AI tool that uses data from patient follow-up studies to estimate the speed of disease progression and identify patterns of muscle decline. The study is published in npj Digital Medicine.